Company: SINT
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001641172-25-024040
Chunk: 12

Company: Sintx Technologies, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Item 8
Chunk 12
---
 to the acquisition of Sinaptic Surgical (see Note 13).

    13

7.
Debt

Insurance
Premium Finance Arrangements

In
June 2024, in connection with securing commercial liability insurance, the Company entered into a Premium Finance Arrangement to extend
the premium payment out for a period of 10 months. The Company paid a total of $26,000 up front toward the insurance premium and financed
approximately $117,000. The Company made 10 equal payments under the terms of the Premium Finance Agreement. The Premium Finance Agreement
bears interest at an annual percentage rate of 8.75%. The loan was paid in full during the first quarter of 2025 and there was no outstanding
balance as of June 30, 2025.

In
March 2025, in connection with securing Director and Officer professional liability insurance, the Company entered into a Premium Finance
Arrangement to extend the premium payment out for a period of 10 months. The Company paid a total of $26,000 up front toward the insurance
premium and financed approximately $145,000. The Company will make 10 equal payments under the terms of the Premium Finance Agreement.
The Premium Finance Agreement bears interest at an annual percentage rate of 7.45%. The outstanding balance totaled $88,000 as of June
30, 2025.

In May 2025, in connection with securing general liability insurance, the Company entered into a Premium Finance Arrangement to extend
the premium payment out for a period of 5 months. The Company paid a total of $14,000 up front toward the insurance premium and financed
approximately $21,000. The Company will make 3 equal payments under the terms of the Premium Finance Agreement. The Premium Finance Agreement
bears interest at an annual percentage rate of 11.15%. The outstanding balance totaled $21,000 as of June 30, 2025.

8.
Equity

2025
Capital Raise and registration of shares

On
February 20, 2025, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) under which it
sold securities to certain institutional and accredited investors for aggregate gross proceeds of $5.0
million, before deducting fees to the placement agent and other expenses payable by the Company in connection with the private
placement. The Company intends to use the net proceeds from the Private Placement for general corporate purposes and working
capital. H.C. Wainwright & Co.